Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
LQDA
#1593
Liquidia Corporation Common Stock
38.710
0
USD
-0.36%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.36%
Changement Mensuel
+5.42%
Evolution sur 6 mois
+71.28%
Changement Annuel
+71.28%
Clôture Précédente
38.850
0
Open
38.660
0
Bid
Ask
Low
38.660
0
High
38.710
0
Volume
80
Marchés
Actions des Marchés US
Soins de Santé
LQDA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.34 M
52.44 M
64.69 M
76.03 M
85.3 M
88.11 M
—
Valuation ratios
Enterprise value
78.49 M
213.28 M
324.78 M
816.13 M
826.63 M
2.85 B
6.66 B
Price to earnings ratio
-1.15
-6.96
-9.09
-9.53
-7.08
-43.11
-75.15
Price to sales ratio
73.72
18.82
23.3
42.85
66.13
18.75
182.95
Price to cash flow ratio
-1.01
-7.11
-12.99
-18.03
-9.91
-83.17
-122.88
Price to book ratio
0.77
3.71
4.11
15.85
11.98
66.33
85.55
Enterprise value to EBITDA ratio
-2.35
-20.77
-18.69
-29.52
-12.2
-74.97
-120.41
Profitability ratios
Return on assets %
-0.6
-0.37
-0.32
-0.66
-0.57
-0.21
-0.3
Return on equity %
-0.84
-0.53
-0.45
-1.66
-1.69
-1.54
-3.34
Return on invested capital %
-641.93
-384.28
-471.63
-872.14
-943.32
-182.12
—
Gross margin %
73.74
76.48
82.06
83.49
58
99.68
351.38
Operating margin %
-7 989.03
-262.94
-243.3
-419.62
-866.63
-32.45
-1 535.07
EBITDA margin %
-3 591.18
-74.1
-100.95
-153.6
-484
-24
-1 299.35
Net margin %
-8 080.11
-269.02
-257.39
-448.89
-931.65
-43.53
-1 690.91
Liquidity ratios
Quick ratio
—
—
—
—
4.42
1.84
9.12
Current ratio
5.63
8.36
11.34
4.85
4.43
2.01
9.64
Inventory turnover
—
—
—
—
24.39
0.04
—
Asset turnover
0.01
0.13
0.14
0.14
0.08
0.57
0.56
Solvency ratios
Debt to assets ratio
0.16
0.16
0.19
0.2
—
—
—
Debt to equity ratio
0.22
0.24
0.27
0.49
—
—
—
Long term debt to total assets ratio
0.1
0.11
0.15
0.17
—
—
—
Long term debt to total equity ratio
0.14
0.16
0.22
0.42
—
—
—
Per share metrics
Operating cash flow per share
-2.93
-0.69
-0.47
-0.64
-1.19
-0.41
-0.42
EBIT per share
-3.2
-0.68
-0.64
-1.13
-1.54
-0.6
-0.6
EBITDA per share
-1.44
-0.19
-0.26
-0.41
-0.86
-0.44
-0.51
Total debt per share
0.86
0.31
0.4
0.36
—
—
—
Cash per share
3.53
1.16
1.53
1.29
2.24
2.22
8.06
Net current asset value per share
3.57
1.23
1.64
1.38
2.35
3.18
10.17
Tangible book value per share
3.34
1.15
1.36
0.61
0.89
0.44
1.21
Working capital per share
2.94
1.09
1.49
1.1
1.82
1.6
5.77
Book value per share
3.85
1.31
1.48
0.73
0.98
0.52
1.54
Nouvelles
Le directeur commercial de Liquidia Corp (LQDA) vend pour 280.000$ d’actions
Le directeur commercial de Liquidia Corp vend pour 404.000$ d’actions
Le directeur comptable de Liquidia, Boyle, vend pour 195.000$ d’actions LQDA
La CHRO de Liquidia Corp, Krepp, vend pour 174.852$ d’actions LQDA
Le directeur financier de Liquidia, Kaseta, vend pour 1,68 million de dollars d’actions LQDA
Le PDG de Liquidia, Jeffs, vend pour 1 million de dollars d’actions LQDA
Le directeur financier de Liquidia, Kaseta, vend pour 5,3 M$ d’actions LQDA
Aris Mining Stock, Franco-Nevada, HSBC Among 30 New Stocks On IBD Watchlists
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
Le directeur de Liquidia Corp, Bloch, vend pour 2,53 millions de dollars d’actions
Novartis Bolsters Immunology Pipeline With Excellergy Deal